- Trials with a EudraCT protocol (5)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
5 result(s) found for: Eflornithine.
Displaying page 1 of 1.
EudraCT Number: 2012-000427-41 | Sponsor Protocol Number: CPPFAP-310 | Start Date*: 2014-05-15 |
Sponsor Name:Cancer Prevention Pharmaceuticals, Inc. | ||
Full Title: A Double-Blind, Randomized, Phase III Trial of the Safety and Efficacy of CPP-1X/Sulindac Compared With CPP-1X, Sulindac as Single Agents in Patients with Familial Adenomatous Polyposis (FAP) | ||
Medical condition: Familial Adenomatous Polyposis (FAP) | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) DE (Completed) NL (Completed) ES (Completed) BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2016-000089-45 | Sponsor Protocol Number: OT-15-001 | Start Date*: 2016-11-07 | |||||||||||
Sponsor Name:Orbus Therapeutics, Inc. | |||||||||||||
Full Title: A Phase 3, Randomized, Open-Label Study To Evaluate the Efficacy and Safety of Eflornithine with Lomustine Compared to Lomustine Alone in Patients with Anaplastic Astrocytoma That Progress/Recur Af... | |||||||||||||
Medical condition: Anaplastic Astrocytoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Restarted) BE (Ongoing) NL (Ongoing) IT (Temporarily Halted) GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-002833-19 | Sponsor Protocol Number: SPD488-402 | Start Date*: 2006-10-12 | |||||||||||
Sponsor Name:Shire Pharmaceutical Development | |||||||||||||
Full Title: A randomised, multi-centre, open-label study to evaluate the efficacy of VANIQA with laser treatment versus laser treatment alone in female subjects with excessive facial hair (facial hirsutism) | |||||||||||||
Medical condition: Excessive facial hair in females (Facial hirsutism) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: AT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-000726-78 | Sponsor Protocol Number: SPD488-401 | Start Date*: 2004-12-02 |
Sponsor Name:Shire Pharmaceuticals Group plc | ||
Full Title: A 24 Week Randomised Double Blind Placebo Controlled Study to Evaluate the Atrophogenic Potential of Eflornithine in the Treatment of Women with Excessive Facial Hair | ||
Medical condition: Facial Hirsutism in Women | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: ES (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-003537-41 | Sponsor Protocol Number: VAN001/2005 | Start Date*: 2005-10-27 |
Sponsor Name:TRICHOLOG GmbH | ||
Full Title: Efficacy of the treatment with VANIQA 11,5% creme in patients suffering from hirsutism of the upper lip | ||
Medical condition: Hirsutism of the upper lip in female patients suffering from increased hair growth in the face | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: DE (Ongoing) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.